Research ArticleArticle
Causal Attributions about Disease Onset and Relapse in Patients with Systemic Vasculitis
Peter C. Grayson, Naomi A. Amudala, Carol A. McAlear, Renée L. Leduc, Denise Shereff, Rachel Richesson, Liana Fraenkel and Peter A. Merkel
The Journal of Rheumatology March 2014, jrheum.131096; DOI: https://doi.org/10.3899/jrheum.131096
Peter C. Grayson
From the US National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania; University of South Florida, Tampa, Florida; School of Nursing, Duke University, Durham, North Carolina; Division of Rheumatology, Yale University, New Haven, Connecticut, USA. Sponsored by the Vasculitis Clinical Research Consortium, which has received support from NIAMS (U54AR057319), the National Center for Research Resources (U54 RR019497); the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. Dr. Grayson receives support from an American College of Rheumatology-Rheumatology Research Foundation Scientist Development Award. Dr. Fraenkel receives support from NIAMS (K24 AR060231-01). P.C. Grayson, MD, MSc, NIH, NIAMS, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; N.A. Amudala, RN, FNP-BC, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; C.A. McAlear, MS, Division of Rheumatology, University of Pennsylvania; R.L. Leduc, BSW; D. Shereff, MLIS, AHIP, University of South Florida; R. Richesson, PhD, MPH, School of Nursing, Duke University; L. Fraenkel, MD, MPH, Division of Rheumatology, Yale University; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. P.C. Grayson, National Institutes of Health, 10 Center Drive, Building 10, Room 13C101A, Bethesda, Maryland 20892, USA. E-mail: peter.grayson@nih.gov. Accepted for publication January 7, 2014.
Naomi A. Amudala
From the US National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania; University of South Florida, Tampa, Florida; School of Nursing, Duke University, Durham, North Carolina; Division of Rheumatology, Yale University, New Haven, Connecticut, USA. Sponsored by the Vasculitis Clinical Research Consortium, which has received support from NIAMS (U54AR057319), the National Center for Research Resources (U54 RR019497); the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. Dr. Grayson receives support from an American College of Rheumatology-Rheumatology Research Foundation Scientist Development Award. Dr. Fraenkel receives support from NIAMS (K24 AR060231-01). P.C. Grayson, MD, MSc, NIH, NIAMS, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; N.A. Amudala, RN, FNP-BC, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; C.A. McAlear, MS, Division of Rheumatology, University of Pennsylvania; R.L. Leduc, BSW; D. Shereff, MLIS, AHIP, University of South Florida; R. Richesson, PhD, MPH, School of Nursing, Duke University; L. Fraenkel, MD, MPH, Division of Rheumatology, Yale University; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. P.C. Grayson, National Institutes of Health, 10 Center Drive, Building 10, Room 13C101A, Bethesda, Maryland 20892, USA. E-mail: peter.grayson@nih.gov. Accepted for publication January 7, 2014.
Carol A. McAlear
From the US National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania; University of South Florida, Tampa, Florida; School of Nursing, Duke University, Durham, North Carolina; Division of Rheumatology, Yale University, New Haven, Connecticut, USA. Sponsored by the Vasculitis Clinical Research Consortium, which has received support from NIAMS (U54AR057319), the National Center for Research Resources (U54 RR019497); the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. Dr. Grayson receives support from an American College of Rheumatology-Rheumatology Research Foundation Scientist Development Award. Dr. Fraenkel receives support from NIAMS (K24 AR060231-01). P.C. Grayson, MD, MSc, NIH, NIAMS, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; N.A. Amudala, RN, FNP-BC, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; C.A. McAlear, MS, Division of Rheumatology, University of Pennsylvania; R.L. Leduc, BSW; D. Shereff, MLIS, AHIP, University of South Florida; R. Richesson, PhD, MPH, School of Nursing, Duke University; L. Fraenkel, MD, MPH, Division of Rheumatology, Yale University; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. P.C. Grayson, National Institutes of Health, 10 Center Drive, Building 10, Room 13C101A, Bethesda, Maryland 20892, USA. E-mail: peter.grayson@nih.gov. Accepted for publication January 7, 2014.
Renée L. Leduc
From the US National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania; University of South Florida, Tampa, Florida; School of Nursing, Duke University, Durham, North Carolina; Division of Rheumatology, Yale University, New Haven, Connecticut, USA. Sponsored by the Vasculitis Clinical Research Consortium, which has received support from NIAMS (U54AR057319), the National Center for Research Resources (U54 RR019497); the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. Dr. Grayson receives support from an American College of Rheumatology-Rheumatology Research Foundation Scientist Development Award. Dr. Fraenkel receives support from NIAMS (K24 AR060231-01). P.C. Grayson, MD, MSc, NIH, NIAMS, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; N.A. Amudala, RN, FNP-BC, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; C.A. McAlear, MS, Division of Rheumatology, University of Pennsylvania; R.L. Leduc, BSW; D. Shereff, MLIS, AHIP, University of South Florida; R. Richesson, PhD, MPH, School of Nursing, Duke University; L. Fraenkel, MD, MPH, Division of Rheumatology, Yale University; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. P.C. Grayson, National Institutes of Health, 10 Center Drive, Building 10, Room 13C101A, Bethesda, Maryland 20892, USA. E-mail: peter.grayson@nih.gov. Accepted for publication January 7, 2014.
Denise Shereff
From the US National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania; University of South Florida, Tampa, Florida; School of Nursing, Duke University, Durham, North Carolina; Division of Rheumatology, Yale University, New Haven, Connecticut, USA. Sponsored by the Vasculitis Clinical Research Consortium, which has received support from NIAMS (U54AR057319), the National Center for Research Resources (U54 RR019497); the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. Dr. Grayson receives support from an American College of Rheumatology-Rheumatology Research Foundation Scientist Development Award. Dr. Fraenkel receives support from NIAMS (K24 AR060231-01). P.C. Grayson, MD, MSc, NIH, NIAMS, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; N.A. Amudala, RN, FNP-BC, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; C.A. McAlear, MS, Division of Rheumatology, University of Pennsylvania; R.L. Leduc, BSW; D. Shereff, MLIS, AHIP, University of South Florida; R. Richesson, PhD, MPH, School of Nursing, Duke University; L. Fraenkel, MD, MPH, Division of Rheumatology, Yale University; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. P.C. Grayson, National Institutes of Health, 10 Center Drive, Building 10, Room 13C101A, Bethesda, Maryland 20892, USA. E-mail: peter.grayson@nih.gov. Accepted for publication January 7, 2014.
Rachel Richesson
From the US National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania; University of South Florida, Tampa, Florida; School of Nursing, Duke University, Durham, North Carolina; Division of Rheumatology, Yale University, New Haven, Connecticut, USA. Sponsored by the Vasculitis Clinical Research Consortium, which has received support from NIAMS (U54AR057319), the National Center for Research Resources (U54 RR019497); the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. Dr. Grayson receives support from an American College of Rheumatology-Rheumatology Research Foundation Scientist Development Award. Dr. Fraenkel receives support from NIAMS (K24 AR060231-01). P.C. Grayson, MD, MSc, NIH, NIAMS, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; N.A. Amudala, RN, FNP-BC, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; C.A. McAlear, MS, Division of Rheumatology, University of Pennsylvania; R.L. Leduc, BSW; D. Shereff, MLIS, AHIP, University of South Florida; R. Richesson, PhD, MPH, School of Nursing, Duke University; L. Fraenkel, MD, MPH, Division of Rheumatology, Yale University; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. P.C. Grayson, National Institutes of Health, 10 Center Drive, Building 10, Room 13C101A, Bethesda, Maryland 20892, USA. E-mail: peter.grayson@nih.gov. Accepted for publication January 7, 2014.
Liana Fraenkel
From the US National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania; University of South Florida, Tampa, Florida; School of Nursing, Duke University, Durham, North Carolina; Division of Rheumatology, Yale University, New Haven, Connecticut, USA. Sponsored by the Vasculitis Clinical Research Consortium, which has received support from NIAMS (U54AR057319), the National Center for Research Resources (U54 RR019497); the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. Dr. Grayson receives support from an American College of Rheumatology-Rheumatology Research Foundation Scientist Development Award. Dr. Fraenkel receives support from NIAMS (K24 AR060231-01). P.C. Grayson, MD, MSc, NIH, NIAMS, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; N.A. Amudala, RN, FNP-BC, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; C.A. McAlear, MS, Division of Rheumatology, University of Pennsylvania; R.L. Leduc, BSW; D. Shereff, MLIS, AHIP, University of South Florida; R. Richesson, PhD, MPH, School of Nursing, Duke University; L. Fraenkel, MD, MPH, Division of Rheumatology, Yale University; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. P.C. Grayson, National Institutes of Health, 10 Center Drive, Building 10, Room 13C101A, Bethesda, Maryland 20892, USA. E-mail: peter.grayson@nih.gov. Accepted for publication January 7, 2014.
Peter A. Merkel
From the US National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania; University of South Florida, Tampa, Florida; School of Nursing, Duke University, Durham, North Carolina; Division of Rheumatology, Yale University, New Haven, Connecticut, USA. Sponsored by the Vasculitis Clinical Research Consortium, which has received support from NIAMS (U54AR057319), the National Center for Research Resources (U54 RR019497); the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. Dr. Grayson receives support from an American College of Rheumatology-Rheumatology Research Foundation Scientist Development Award. Dr. Fraenkel receives support from NIAMS (K24 AR060231-01). P.C. Grayson, MD, MSc, NIH, NIAMS, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; N.A. Amudala, RN, FNP-BC, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; C.A. McAlear, MS, Division of Rheumatology, University of Pennsylvania; R.L. Leduc, BSW; D. Shereff, MLIS, AHIP, University of South Florida; R. Richesson, PhD, MPH, School of Nursing, Duke University; L. Fraenkel, MD, MPH, Division of Rheumatology, Yale University; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. P.C. Grayson, National Institutes of Health, 10 Center Drive, Building 10, Room 13C101A, Bethesda, Maryland 20892, USA. E-mail: peter.grayson@nih.gov. Accepted for publication January 7, 2014.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Causal Attributions about Disease Onset and Relapse in Patients with Systemic Vasculitis
Peter C. Grayson, Naomi A. Amudala, Carol A. McAlear, Renée L. Leduc, Denise Shereff, Rachel Richesson, Liana Fraenkel, Peter A. Merkel
The Journal of Rheumatology Mar 2014, jrheum.131096; DOI: 10.3899/jrheum.131096
Causal Attributions about Disease Onset and Relapse in Patients with Systemic Vasculitis
Peter C. Grayson, Naomi A. Amudala, Carol A. McAlear, Renée L. Leduc, Denise Shereff, Rachel Richesson, Liana Fraenkel, Peter A. Merkel
The Journal of Rheumatology Mar 2014, jrheum.131096; DOI: 10.3899/jrheum.131096